Jochen Wöhrle

ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting

Stefanie Schüpke, Robert A. Byrne, Jurriën M. ten Berg et al. · European Heart Journal · 2015 · 423 citations · Full text

Comprehensive Prognosis Assessment by CMR Imaging After ST-Segment Elevation Myocardial Infarction

Ingo Eitel, Suzanne de Waha, Jochen Wöhrle et al. · Journal of the American College of Cardiology · 2014 · 386 citations

Medical Imaging, Cardiovascular Disease, Myocardial Infarction +11

Intracoronary Compared With Intravenous Bolus Abciximab Application During Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction

Ingo Eitel, Jochen Wöhrle, Henning Suenkel et al. · Journal of the American College of Cardiology · 2013 · 175 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +10

A randomized trial of elective stenting after balloon recanalization of chronic total occlusions

Martin Höher, Jochen Wöhrle, Olaf Grebe et al. · Journal of the American College of Cardiology · 1999 · 126 citations

Endovascular Technique, Cardiovascular Disease, Chronic Total Occlusions +9

Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: Design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trial

Hölger Thiele, Jochen Wöhrle, Petra Neuhaus et al. · American Heart Journal · 2010 · 67 citations

Aida Stemi, Percutaneous Coronary Intervention, Cardiovascular Disease +12